Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI announces first doses in new clinical trial of innovative HIV vaccine candidate

July 3, 2023

Sequential immunization approach used furthers IAVI’s HIV vaccine development.

Read more

Features

IAVI salutes commitments to TB vaccine R&D

June 29, 2023

Wellcome and Gates Foundation announce plans to fund a Phase III clinical trial of the tuberculosis vaccine candidate M72 in adults.

Read more

Features

Three new articles highlight the health economics of HIV prevention technologies

June 8, 2023

This series of articles in PharmacoEconomics are designed to map evidence gaps and identify health economic research priorities for the HIV prevention field.

Read more

Features

Meet The Scientist podcast: An interview with Gabriela Gomez, senior director of global access at IAVI

June 6, 2023

The first episode of Meet The Scientist, IAVI’s new podcast series, will explore the importance of economic modeling for TB vaccine R&D.

Read more

Features

Novel HIV vaccine candidate stimulates immune response in T cells

May 25, 2023

New analysis of IAVI G001 trial shows nanoparticle HIV vaccine creates strong immune response in helper T cells

Read more

Features

New IAVI paper makes the case for strengthening clinical and regulatory pathways to accelerate global access to monoclonal antibodies

May 10, 2023

Expanded access would benefit many in low- and middle-income countries.

Read more

Features

IAVI Board member Wafaa El-Sadr honored

April 28, 2023

IAVI Board member and ICAP founder Wafaa El-Sadr recognized for her contributions to global health.

Read more

Features

IAVI leaders to participate in World Vaccine Congress

March 30, 2023

Presentations will focus on vaccines for HIV, neglected diseases, and pandemic preparedness.

Read more